Dihydrotanshinone I inhibits hepatocellular carcinoma cells proliferation through DNA damage and EGFR pathway.

Wang, Linjun; Xu, Xiangwei; Chen, Dexing; Li, Chenghang

Wang, Linjun; Xu, Xiangwei; Chen, Dexing; Li, Chenghang.

Afiliação

Wang L; Department of Hepatopancreatobiliary Surgery, The First People's Hospital of Yongkang, Yongkang, Zhejiang, China.
Xu X; Department of Pharmacy, The First People's Hosipital of Yongkang, Yongkang, Zhejiang, China.
Chen D; Department of Hepatopancreatobiliary Surgery, The First People's Hospital of Yongkang, Yongkang, Zhejiang, China.
Li C; Department of Infectious Liver Disease, The First People's Hospital of Yongkang, Yongkang, Zhejiang, China.

PeerJ ; 11: e15022, 2023.

Article em En | MEDLINE | ID: mdl-36935927

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/tratamento farmacológico; Neoplasias Hepáticas/tratamento farmacológico; Dano ao DNA/genética; Proliferação de Células; Receptores ErbB/genética

Palavras-chave

DNA damage; EGFR; Hepatocellular carcinoma; Proliferation; Dihydrotanshinone I

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google